Clinical Trial Update: IKKb-matured, RNA-loaded Dendritic Cells for Metastasised Uveal Melanoma [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating an IKKβ-matured, RNA-loaded dendritic cell therapy for metastatic uveal melanoma has completed. The trial investigated a novel dendri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveal Melanoma

Drugs mentioned

• IKKb-matured, RNA-loaded Dendritic Cells

Snippet

Sponsor: Hasumi International Research Foundation | Conditions: Melanoma, Uveal Metastatic | Phase 1 | Status: COMPLETED